COVAXIN Trademark

Trademark Overview

On Monday, March 1, 2021, a trademark application was filed for COVAXIN with the United States Patent and Trademark Office. The USPTO has given the COVAXIN trademark a serial number of 90551989. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, June 24, 2024. This trademark is owned by BHARAT BIOTECH INTERNATIONAL LIMITED. The COVAXIN trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use in treating and reducing the risk of contagious diseases caused by coronavirus
covaxin

General Information

Serial Number90551989
Word MarkCOVAXIN
Filing DateMonday, March 1, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, June 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2022

Trademark Statements

Goods and ServicesVaccines for human use in treating and reducing the risk of contagious diseases caused by coronavirus

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBHARAT BIOTECH INTERNATIONAL LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHyderabad, Telangana 500078
IN
Party NameBHARAT BIOTECH INTERNATIONAL LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHyderabad, Telangana 500078
IN

Trademark Events

Event DateEvent Description
Thursday, March 4, 2021NEW APPLICATION ENTERED
Saturday, May 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 21, 2021ASSIGNED TO EXAMINER
Wednesday, September 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 22, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 18, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, March 18, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 18, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 18, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2022SOU EXTENSION 1 FILED
Tuesday, November 29, 2022SOU EXTENSION 1 GRANTED
Thursday, December 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 2 FILED
Monday, June 26, 2023SOU EXTENSION 2 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 22, 2023SOU EXTENSION 3 FILED
Friday, December 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 22, 2023SOU EXTENSION 3 GRANTED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU EXTENSION 4 GRANTED
Monday, June 24, 2024SOU EXTENSION 4 FILED
Tuesday, December 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

covaxin diseases caused coronavirus contagious risk human treating reducing vaccines